Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Historical Article1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Pharmacology1
Search Results
Sort by
- BookStuart Metcalfe, Ian Reilly ; foreword by Bill Ribbans.Contents:
Local anaesthetics
Applications of local anaesthetics
Patient suitability for local anaesthetic
Calculating maximum safe doses
Complications of peripheral nerve blocks
Nerve stimulators
The basics
Basic local anaesthetic techniques
Advanced local anaesthetic techniques
Corticosteroid injection therapy
Common foot and ankle conditions: joint injections
Common foot and ankle conditions: soft tissue injections
Other injection therapies.Digital Access ScienceDirect 2010 - ArticleHofmann A.Pharmacology. 1978;16 Suppl 1:1-11.A short survey of the history of ergot, of the original and, for a long time, only source of ergot alkaloids, is given. Once a dreaded poison, ergot has changed its role over the centuries to become a rich treasure house of valuable pharmaceuticals. In the Middle Ages it was the cause of epidemics of ergotism, which cost tens of thousands of people their lives. Ergot was first mentioned by the German physician Lonitzer in 1582 as a remedy used by midwives for quickening childbirth. The isolation of pharmacologically useful alkaloids started in 1906 with the discovery of ergotoxine and its adrenolytic activity by Barger, Carr and Dale. In 1918, Stoll isolated ergotamine, the first chemically pure ergot alkaloid, which found widespread therapeutic use in obstetrics and internal medicine. In 1935 the specific oxytocic principle of ergot, ergonovine, was discovered simultaneously in four separate laboratories. Since then, worldwide investigations on ergot alkaloids resulted in the elucidation of their structures and total syntheses and preparation of valuable therapeutics such as Methergine, Hydergine, Dihydergot, and others.